The two positions should not be read as a broad endorsement of cannabis. Rather, the AMA’s framing points to a narrow, closely monitored use case for a specific population, alongside ongoing concern about products that appeal to younger users.

A Cautious Shift, Not a Green Light

Older adults are now the fastest-growing group of marijuana users nationally, often turning to it as an alternative to other medications for pain, sleep or inflammation.

The AMA’s acknowledgment reflects growing clinical interest as evidence accumulates, but it comes with meaningful caveats. Cannabis is not a substitute for a physician-supervised treatment plan, and its use in older adults carries specific risks that differ from those in younger populations.

Real Risks That Come With Real Limitations

Older adults metabolize substances differently than younger adults, which raises the risk of drug interactions, particularly with blood thinners, sedatives, and blood pressure medication.

Cannabis use has also been associated with dizziness, impaired balance and fall risk in older adults, along with the potential to worsen cognitive symptoms in people with dementia or mild cognitive impairment.

None of this is addressed by simply acknowledging a potential benefit. It requires ongoing monitoring by a physician who knows a patient’s full medication list and health history, not a one-time conversation or self-directed use.

Vape Restrictions Reflect a Separate, Youth-Focused Concern

The AMA’s push for flavored vape restrictions is aimed at a different population and a different risk, underage access and appeal. Flavored cannabis and nicotine vapes have drawn regulatory scrutiny in several states, with public health officials repeatedly citing flavoring as a driver of youth use.

Reading the AMA’s two positions together shows a more cautious, population-specific approach to cannabis than a blanket policy shift in either direction.

What This Means for Treatment Seekers

For families evaluating whether cannabis is appropriate for an older relative, or for anyone questioning their own use, this AMA position is not a reason to start or continue cannabis use without medical guidance.

Regular use can still contribute to dependence, and it can complicate underlying mental health conditions like anxiety or depression.

Anyone using cannabis heavily, or struggling to cut back, may benefit from an evaluation by a treatment provider familiar with cannabis use disorder, especially given the added risk profile in older adults.

Exploring Treatment Options

People concerned about their own or a loved one’s cannabis use can start by comparing rehab centers that offer outpatient care for cannabis use disorder, asking a physician directly about interaction risks with existing medications, and confirming any provider’s credentials before beginning treatment or ongoing monitoring.

Rehab.com’s directory includes verified rehab centers that can help evaluate whether cannabis use has become a larger concern. Call 800-985-8516 ( Question iconSponsored Helpline ) to speak with a treatment advisor.